Insception Biosciences
Mississauga · Founded 1996
About Insception Biosciences
Insception is the largest cord blood program in Canada with over 39,000 cord blood units banked. Insception is owned by Argosy Partners, Mount Sinai Hospital, management and its scientific founders. By partnering with leading Canadian medical facilities such as Toronto's Mount Sinai and the Scarborough Hospitals, Insception continues to work closely with Canada's leading healthcare providers. The Insception Cord Blood Program is able to provide every Canadian family with security, state of the art processing and storage, financial stability and long term professional governance.
Company Facts
- Founded: 1996
- Legal name: Insception Bioscience Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $7.2M
- Last round: Debt Financing (Sep 2012)
- Website: insception.com
- Phone: +1 905-206-2790
Social Profiles
Canonical: https://fsome.com/organization/insception-biosciences-8240815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.